Status:
COMPLETED
Detection of Postoperative Respiratory Depression in High Risk Patients Utilizing Minute Ventilation Monitoring
Lead Sponsor:
Yale University
Conditions:
Respiratory Depression
Eligibility:
All Genders
18-80 years
Brief Summary
Respiratory volume monitor (RVM) (ExSpiron) is superior to continuous pulse oximetry in detection of postoperative respiratory depression in high risk patients.
Detailed Description
Aims are to: 1) Estimate the incidence of postoperative respiratory depression in high risk patients as detected by continuous pulse oximetry 2) Estimate the incidence of postoperative respiratory dep...
Eligibility Criteria
Inclusion
- Patients who suffered rib fractures or patients who are weaned from mechanical ventilation and recently extubated.
Exclusion
- Have known contraindication/allergy to neuroaxial/paravertebral nerve block anesthesia
- Patients allergic to morphine.
- Have an ASA class \> IV
Key Trial Info
Start Date :
June 20 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 20 2020
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT04017702
Start Date
June 20 2018
End Date
February 20 2020
Last Update
April 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale New Haven Hospital
New Haven, Connecticut, United States, 06519-1362